Induction of gp120-specific protective immune responses by genetic vaccination with linear polyethylenimine-plasmid complex (Q45231614)

11 December 2017

Induction of gp120-specific protective immune responses by genetic vaccination with linear polyethylenimine-plasmid complex (English)

1 reference

11 December 2017

6

1 reference

11 December 2017

10

1 reference

11 December 2017

11

1 reference

Gloria González Aseguinolaza

11 December 2017

12

object named as

Gloria González-Aseguinolaza

1 reference

11 December 2017

2

Pedro Berraondo

1 reference

11 December 2017

3

Julien Crettaz

1 reference

11 December 2017

Manolo Rodrigo Garzón

1

1 reference

11 December 2017

Laura Ochoa

4

1 reference

11 December 2017

Maria Vera

5

1 reference

11 December 2017

Africa Vales

7

1 reference

11 December 2017

Nico Van Rooijen

8

1 reference

11 December 2017

Juan Ruiz

9

1 reference

11 December 2017

language of work or name

English

0 references

publication date

1 February 2005

1 reference

11 December 2017

9

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

11 December 2017

23

1 reference

11 December 2017

11

1 reference

11 December 2017

1384-1392

1 reference

Prevention of HIV-2 and SIVsm infection by passive immunization in cynomolgus monkeys

11 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.009

Prevention of HIV-1 infection in chimpanzees by gpl20 V3 domain-specific monoclonal antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.009

Cellular immune responses to HIV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.009

Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.009

Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.009

Immunization with a modified vaccinia virus expressing simian immunodeficiency virus (SIV) Gag-Pol primes for an anamnestic Gag-specific cytotoxic T-lymphocyte response and is associated with reduction of viremia after SIV challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.009

Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.009

Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.009

Role of CD8(+) lymphocytes in control of simian immunodeficiency virus infection and resistance to rechallenge after transient early antiretroviral treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.009

Design and tests of an HIV vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.009

Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.009

Potent CD4+ T cell responses elicited by a bicistronic HIV-1 DNA vaccine expressing gp120 and GM-CSF

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.009

Functional equivalency of B7-1 and B7-2 for costimulating plasmid DNA vaccine-elicited CTL responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.009

Coadministration of HIV vaccine vectors with vaccinia viruses expressing IL-15 but not IL-2 induces long-lasting cellular immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.009

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.009

Heterologous protection against influenza by injection of DNA encoding a viral protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.009

Induction of CD4(+) T cell-dependent CD8(+) type 1 responses in humans by a malaria DNA vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.009

First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.009

7 January 2021

DNA vaccines: a review

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.009

Induction of specific immune responses by polycation-based vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.009

A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.009

Intracellular route and transcriptional competence of polyethylenimine-DNA complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.009

Different behavior of branched and linear polyethylenimine for gene delivery in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.009

Prolonged organ retention and safety of plasmid DNA administered in polyethylenimine complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.009

Polyethylenimine shows properties of interest for cystic fibrosis gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.009

Genetic immunization with lung-targeting macroaggregated polyethyleneimine-albumin conjugates elicits combined systemic and mucosal immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.009

ELISPOT assay to measure antigen-specific murine CD8(+) T cell responses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.009

Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.009

Apoptosis of macrophages induced by liposome-mediated intracellular delivery of clodronate and propamidine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.009

Immunostimulatory DNA sequences necessary for effective intradermal gene immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.009

Side-effects of a systemic injection of linear polyethylenimine-DNA complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.009

Effects of intravenous immunoglobulins on T-cell mediated, concanavalin A-induced hepatitis in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.009

A striking property of recombinant poxviruses: efficient inducers of in vivo expansion of primed CD8(+) T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.009

Advances in vaccine adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.009

Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.09.009

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2004.09.009

1 reference

11 December 2017

1 reference